Arbutus Biopharma (@ArbutusBio) header
Arbutus Biopharma (@ArbutusBio) profile picture

Arbutus (Nasdaq: ABUS) is a biopharma company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic HBV infection.

Joined July 2015
Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)Photo by Arbutus Biopharma (@ArbutusBio)
$ABUS announced that Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloidosis. investor.arbutusbio.com/node…
4
4
15
$ABUS announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference on August 15, 2018 at 2:30 p.m. ET. A live webcast of the presentation can be accessed via the Investors section, under Events and Presentations of Arbutus' website. investor.arbutusbio.com/node…
1
3
1
2
$ABUS announced that it will present at the first annual @Roivant #Pipeline Day on July 10, 2018, at 4:00 p.m. ET. A live webcast will be available via the Investors section, under Events and Presentations of Arbutus' website. investor.arbutusbio.com/node…
3
4
#HepB is the most common serious #liver infection in the world. The #HepB virus attacks liver cells and can lead to liver cancer or liver failure.
1
#Hepatitis B is called a "silent infection" because most people do not have any symptoms when they are first infected. #hepB #HBV #heptitisB ow.ly/9KqO30icfqh
5
3
#DYK that #hepB symptoms usually appear 3 to 4 months after a person gets the virus? But sometimes you may not even see symptoms! Learn more here: hepb.org/blog/diagnosed-with…
2
2
Arbutus Biopharma retweeted
This #WDHD2018 download the NOhep Advocacy Toolkit - https://nitter.cf/t.co/l9lz6uN1v0. #NOhep ​gph.is/2xpWN6M
6
6
The #HepB virus can survive outside the body for 7 days and still be capable of causing infection. You can learn more here: cdc.gov/hepatitis/hbv/hbvfaq… #HepatitisAwarenessMonth
2
2
1,800 people in the United States die of #HepB related liver diseases each year. Check out more statistics here: cdc.gov/hepatitis/resources/… #HepatitisAwarenessMonth @cdchep
2
1
Arbutus Biopharma retweeted
We have viral #hepatitis fact sheets in multiple languages! Visit go.usa.gov/xQxZr for fact sheets on #hepB and #hepC! #NOHep #HepAware
For every 1,000 #pregnant women that give birth each year, an estimated 1 to 2 of them have #HepB, which can easily spread to their babies. Learn more here: cdc.gov/hepatitis/hbv/pdfs/H… #HepatitisAwarenessMonth @cdchep
3
3
Arbutus Biopharma retweeted
There an estimated 237 million people living with #HepB worldwide and yet only 9% of those are aware of their diagnosis. To prevent these people developing liver disease or cancer in the future we must find them and link them to care NOW! #NOhep
15
17
#ICYMI $ABUS held a conference call to discuss first quarter 2018 financial results. Check out the recorded webcast here: edge.media-server.com/m6/p/b…
1
Ready to increase awareness of #hepatitis B during #HepatitisAwarenessMonth, but not sure how? Check out our latest blog post about for some tips on how you can get involved this month! ow.ly/5MRb30jMaiS #HepatitisAwarenessMonth #AAPIHeritageMonth #APAHM #hepB #hepatitisB
1
2
•#HepB is the most common serious liver #infection in the world. An estimated 350 million people worldwide are chronically infected. Learn more here: cdc.gov/hepatitis/HBV/PDFs/H… #HepatitisAwarenessMonth
3
2
Arbutus Biopharma retweeted
It's May! In the US, May is Hepatitis Awareness Month! Follow us and re-tweet us over the coming month to raise awareness that we can #eliminate viral #hepatitis! #NOhep
8
2
19
$ABUS Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results investor.arbutusbio.com/news…
2
1
#HBV is the cause of up to 80% of #livercancers. Liver cancer patients typically have a five-year survival rate of only 15%. $ABUS is dedicated to finding a cure for #HepB. Learn more from our recent #EASL2018 presentations: investor.arbutusbio.com/even…. #ILC2018
3
2
$ABUS evaluated the anti-#HBV activities of two novel orally administered agents in combination with standard of care treatment & the investigational RNA interference agent, ARB-1467. Learn more at our #EASL2018 presentation in the session HBV cure: Pre-clinical studies. #ILC2018
1
2
Learn more about a promising new agent to potentiate HBV cure that acts on multiple #HBV viral transcripts, enabling inhibition of HBV replication and suppression of all viral antigens at our #EASL2018 parallel session oral presentation today. #ILC2018
1
2
6
Don't miss it! Amy Lee is presenting now on a promising new agent to potentiate HBV cure that acts on multiple #HBV viral transcripts, enabling inhibition of HBV replication and suppression of all viral antigens. #ILC2018
2
3